MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.
Curioni-Fontecedro
A
A
Knights
A J
AJ
Tinguely
M
M
Nuber
N
N
Schneider
C
C
Thomson
C W
CW
von Boehmer
L
L
Bossart
W
W
Pahlich
S
S
Gehring
H
H
Moch
H
H
Renner
C
C
Knuth
A
A
Zippelius
A
A
D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000276:immunology*; D001483:Base Sequence; D015153:Blotting, Western; D017931:DNA Primers; D006801:Humans; D009101:Multiple Myeloma / Q000276:immunology*; D009363:Neoplasm Proteins / Q000276:immunology*
D000951:Antigens, Neoplasm; C473332:CT7 antigen, human; D017931:DNA Primers; C110905:MAGEC1 protein, human; D009363:Neoplasm Proteins